NAROPIN (General Injectables & Vaccines, Inc)
Welcome to the PulseAid listing for the NAROPIN drug offered from General Injectables & Vaccines, Inc. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | General Injectables & Vaccines, Inc |
NON-PROPRIETARY NAME: | ropivacaine hydrochloride |
SUBSTANCE NAME: | ROPIVACAINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] |
ROUTE: | EPIDURAL; INFILTRATION; PERINEURAL |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-03-11 |
END MARKETING DATE: | 0000-00-00 |
NAROPIN HUMAN PRESCRIPTION DRUG Details:
Item Description | NAROPIN from General Injectables & Vaccines, Inc |
LABELER NAME: | General Injectables & Vaccines, Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2014-03-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52584-286_a3190270-a817-44a1-b428-03c57fbb3a13 |
PRODUCT NDC: | 52584-286 |
APPLICATION NUMBER: | NDA020533 |
Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: